258 related articles for article (PubMed ID: 31863543)
1. Efficacy of topical ivermectin and impact on quality of life in patients with papulopustular rosacea: A systematic review and meta-analysis.
Husein-ElAhmed H; Steinhoff M
Dermatol Ther; 2020 Jan; 33(1):e13203. PubMed ID: 31863543
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.
Stein L; Kircik L; Fowler J; Tan J; Draelos Z; Fleischer A; Appell M; Steinhoff M; Lynde C; Liu H; Jacovella J
J Drugs Dermatol; 2014 Mar; 13(3):316-23. PubMed ID: 24595578
[TBL] [Abstract][Full Text] [Related]
3. Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials.
Stein Gold L; Kircik L; Fowler J; Jackson JM; Tan J; Draelos Z; Fleischer A; Appell M; Steinhoff M; Lynde C; Sugarman J; Liu H; Jacovella J;
J Drugs Dermatol; 2014 Nov; 13(11):1380-6. PubMed ID: 25607706
[TBL] [Abstract][Full Text] [Related]
4. Superior Efficacy with Ivermectin 1% Cream Compared to Metronidazole 0.75% Cream Contributes to a Better Quality of Life in Patients with Severe Papulopustular Rosacea: A Subanalysis of the Randomized, Investigator-Blinded ATTRACT Study.
Schaller M; Dirschka T; Kemény L; Briantais P; Jacovella J
Dermatol Ther (Heidelb); 2016 Sep; 6(3):427-36. PubMed ID: 27432169
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Ivermectin 1% Cream in Adults with Papulopustular Rosacea in the United States.
Taieb A; Stein Gold L; Feldman SR; Dansk V; Bertranou E
J Manag Care Spec Pharm; 2016 Jun; 22(6):654-65. PubMed ID: 27231793
[TBL] [Abstract][Full Text] [Related]
6. Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial.
Taieb A; Ortonne JP; Ruzicka T; Roszkiewicz J; Berth-Jones J; Peirone MH; Jacovella J;
Br J Dermatol; 2015 Apr; 172(4):1103-10. PubMed ID: 25228137
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled Study.
Gold LS; Papp K; Lynde C; Lain E; Gooderham M; Johnson S; Kerrouche N
J Drugs Dermatol; 2017 Sep; 16(9):909-916. PubMed ID: 28915286
[TBL] [Abstract][Full Text] [Related]
8. A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea.
Schaller M; Kemény L; Havlickova B; Jackson JM; Ambroziak M; Lynde C; Gooderham M; Remenyik E; Del Rosso J; Weglowska J; Chavda R; Kerrouche N; Dirschka T; Johnson S
J Am Acad Dermatol; 2020 Feb; 82(2):336-343. PubMed ID: 31150711
[TBL] [Abstract][Full Text] [Related]
9. Rosacea: new and emerging treatments.
Moustafa FA; Sandoval LF; Feldman SR
Drugs; 2014 Sep; 74(13):1457-65. PubMed ID: 25154627
[TBL] [Abstract][Full Text] [Related]
10. A Review of the Current Modalities for the Treatment of Papulopustular Rosacea.
McGregor SP; Alinia H; Snyder A; Tuchayi SM; Fleischer A; Feldman SR
Dermatol Clin; 2018 Apr; 36(2):135-150. PubMed ID: 29499797
[TBL] [Abstract][Full Text] [Related]
11. Concerns and Treatment Satisfaction in Patients Being Treated With Azelaic Acid Foam for Rosacea.
Williamson T; Cameron J; McLeod K; Turner B; Quillen A; LaRose A; Lott J; Gaiser A
J Drugs Dermatol; 2019 Apr; 18(4):381-386. PubMed ID: 31013011
[TBL] [Abstract][Full Text] [Related]
12. Ivermectin 1% (CD5024) for the treatment of rosacea.
Sahni DR; Feldman SR; Taylor SL
Expert Opin Pharmacother; 2018 Apr; 19(5):511-516. PubMed ID: 29544355
[TBL] [Abstract][Full Text] [Related]
13. Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials.
Liu RH; Smith MK; Basta SA; Farmer ER
Arch Dermatol; 2006 Aug; 142(8):1047-52. PubMed ID: 16924055
[TBL] [Abstract][Full Text] [Related]
14. Topical Ivermectin in the Treatment of Papulopustular Rosacea: A Systematic Review of Evidence and Clinical Guideline Recommendations.
Ebbelaar CCF; Venema AW; Van Dijk MR
Dermatol Ther (Heidelb); 2018 Sep; 8(3):379-387. PubMed ID: 29943217
[TBL] [Abstract][Full Text] [Related]
15. Real-life experience on effectiveness and tolerability of topical ivermectin in papulopustular rosacea and antiparasitic effect on Demodex mites.
Trave I; Merlo G; Cozzani E; Parodi A
Dermatol Ther; 2019 Nov; 32(6):e13093. PubMed ID: 31579993
[TBL] [Abstract][Full Text] [Related]
16. Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea.
Schaller M; Gonser L; Belge K; Braunsdorf C; Nordin R; Scheu A; Borelli C
J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1907-1911. PubMed ID: 28653460
[TBL] [Abstract][Full Text] [Related]
17. Ivermectin 1% cream for rosacea.
Gupta G; Daigle D; Gupta AK; Gold LS
Skin Therapy Lett; 2015; 20(4):9-11. PubMed ID: 26382711
[TBL] [Abstract][Full Text] [Related]
18. Maintenance of remission following successful treatment of papulopustular rosacea with ivermectin 1% cream vs. metronidazole 0.75% cream: 36-week extension of the ATTRACT randomized study.
Taieb A; Khemis A; Ruzicka T; Barańska-Rybak W; Berth-Jones J; Schauber J; Briantais P; Jacovella J; Passeron T;
J Eur Acad Dermatol Venereol; 2016 May; 30(5):829-36. PubMed ID: 26691278
[TBL] [Abstract][Full Text] [Related]
19. The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysis.
Siddiqui K; Stein Gold L; Gill J
Springerplus; 2016; 5(1):1151. PubMed ID: 27504249
[TBL] [Abstract][Full Text] [Related]
20. The treatment of rosacea with topical ivermectin.
Ali ST; Alinia H; Feldman SR
Drugs Today (Barc); 2015 Apr; 51(4):243-50. PubMed ID: 26020066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
